Other Local Peers |
INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BIO-TECHNE CORP (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARVINAS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), INSMED INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), VERACYTE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PERSONALIS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), VIELA BIO INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NANTKWEST INC (NASDAQ), REGENXBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), UNIQURE N.V. (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOATLA INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ALECTOR INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MACROGENICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INHIBRX INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VAXCYTE INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), PASSAGE BIO INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), HUMANIGEN INC (NASDAQ), CURIS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), CORTEXYME INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AFFIMED N V (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), VANDA PHARMACE INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AGENUS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ARDELYX INC (NASDAQ), AVROBIO INC (NASDAQ), ONCORUS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AKOUOS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ATRECA INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), CHIMERIX INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), GERON CORP (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), XBIOTECH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XOMA CORP (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), ATHERSYS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), NEXTCURE INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INMUNE BIO INC (NASDAQ), TREVENA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), KAMADA LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMV INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), METACRINE INC (NASDAQ), OTONOMY INC (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), EVOGENE LTD (NASDAQ), SESEN BIO INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), IMMUNOME INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), SYNLOGIC INC (NASDAQ), ORGENESIS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), SAVARA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), COHBAR INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ADVAXIS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), VACCINEX INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), PRECIPIO INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ATYR PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), GEOVAX LABS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ) |
Other Global Peers |
VIVA BIOTECH (HKEx), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), JW THERAP-B (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), ASCENTAGE-B (HKEx), HAOHAI BIOTEC (HKEx), JHBP-B (HKEx), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SQZ BIOTECHNOLOGIES CO (NYSE), SINOMAB BIO-B (HKEx), KINTOR PHARMA-B (HKEx), DPHARMA (Bursa), OPTHEA LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), IMUGENE LIMITED (ASX), ESSEX BIO-TECH (HKEx), 22ND CENTURY GROUP INC (NYSE American), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), ANTEOTECH LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), BIONOMICS LTD (ASX), UNI-BIO GROUP (HKEx), LEAF RESOURCES LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), MEMPHASYS LTD (ASX), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), ORAGENICS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), CT ENTERPRISE (HKEx), BIOTRON (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), Suntar Eco-City (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), REGENEUS LTD (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NANOLLOSE LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX) |